Autopsy report · NCT03644589

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

“No participants enrolled.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of Washington

Sponsor type

University, hospital or other

Conditions

Estrogen Receptor Negative; HER2/Neu Negative; Metastatic Breast Cancer; Progesterone Receptor Negative; Recurrent Breast Carcinoma; Triple Negative Breast Cancer

Interventions

Pembrolizumab; Cisplatin

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Comparison of Small Colorectal Polyp Removal Using Cold EMR With Hot EMR
  “No participants were enrolled.” (98% match in meaning)
• Remote Ischemic Conditioning in Traumatic Brain Injury
  “No eligible participants were enrolled.” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.